Home Applications 213072 Application 213072
Type NDA
Sponsor ALTHERA LIFE SCIENCES, LLC. Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 ROSZET ROSUVASTATIN CALCIUM; EZETIMIBE TABLET; ORAL 5MG/10MG Yes No 002 ROSZET ROSUVASTATIN CALCIUM; EZETIMIBE TABLET; ORAL 10MG/10MG Yes No 003 ROSZET ROSUVASTATIN CALCIUM; EZETIMIBE TABLET;ORAL 20MG/10MG Yes No 004 ROSZET ROSUVASTATIN CALCIUM; EZETIMIBE TABLET; ORAL 40MG/10MG Yes No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 4 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N213072-001 ROSZET EZETIMIBE; ROSUVASTATIN CALCIUM 10MG;EQ 5MG BASE TABLET / ORAL RLD 2021-03-23 N213072-002 ROSZET EZETIMIBE; ROSUVASTATIN CALCIUM 10MG;EQ 10MG BASE TABLET / ORAL RLD 2021-03-23 N213072-003 ROSZET EZETIMIBE; ROSUVASTATIN CALCIUM 10MG;EQ 20MG BASE TABLET / ORAL RLD 2021-03-23 N213072-004 ROSZET EZETIMIBE; ROSUVASTATIN CALCIUM 10MG;EQ 40MG BASE TABLET / ORAL RLD 2021-03-23
Orange Book patents# Current patent rows page 1 of 1 · 8 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N213072-001 10376470 2033-05-01 U-3095 Drug product 2021-03-29 N213072-001 9763885 2033-05-01 U-3095 Drug product 2021-03-29 N213072-002 10376470 2033-05-01 U-3095 Drug product 2021-03-29 N213072-002 9763885 2033-05-01 U-3095 Drug product 2021-03-29 N213072-003 10376470 2033-05-01 U-3095 Drug product 2021-03-29 N213072-003 9763885 2033-05-01 U-3095 Drug product 2021-03-29 N213072-004 10376470 2033-05-01 U-3095 Drug product 2021-03-29 N213072-004 9763885 2033-05-01 U-3095 Drug product 2021-03-29
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 3 of 4 · 152 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2022-04-04 05:41 UTC 2022-04 N213072-001 ROSZET 10MG;EQ 5MG BASE TABLET / ORAL RLD 2021-03-23 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N213072-002 ROSZET 10MG;EQ 10MG BASE TABLET / ORAL RLD 2021-03-23 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N213072-003 ROSZET 10MG;EQ 20MG BASE TABLET / ORAL RLD 2021-03-23 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N213072-004 ROSZET 10MG;EQ 40MG BASE TABLET / ORAL RLD, RS 2021-03-23 4b0b4de00fa7…2022-03-09 01:35 UTC 2022-03 N213072-001 ROSZET 10MG;EQ 5MG BASE TABLET / ORAL RLD 2021-03-23 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 N213072-002 ROSZET 10MG;EQ 10MG BASE TABLET / ORAL RLD 2021-03-23 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 N213072-003 ROSZET 10MG;EQ 20MG BASE TABLET / ORAL RLD 2021-03-23 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 N213072-004 ROSZET 10MG;EQ 40MG BASE TABLET / ORAL RLD, RS 2021-03-23 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N213072-001 ROSZET 10MG;EQ 5MG BASE TABLET / ORAL RLD 2021-03-23 782e0a99824c…2021-12-28 21:50 UTC 2021-12 N213072-002 ROSZET 10MG;EQ 10MG BASE TABLET / ORAL RLD 2021-03-23 782e0a99824c…2021-12-28 21:50 UTC 2021-12 N213072-003 ROSZET 10MG;EQ 20MG BASE TABLET / ORAL RLD 2021-03-23 782e0a99824c…2021-12-28 21:50 UTC 2021-12 N213072-004 ROSZET 10MG;EQ 40MG BASE TABLET / ORAL RLD, RS 2021-03-23 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N213072-001 ROSZET 10MG;EQ 5MG BASE TABLET / ORAL RLD 2021-03-23 87673890dc5c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N213072-002 ROSZET 10MG;EQ 10MG BASE TABLET / ORAL RLD 2021-03-23 87673890dc5c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N213072-003 ROSZET 10MG;EQ 20MG BASE TABLET / ORAL RLD 2021-03-23 87673890dc5c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N213072-004 ROSZET 10MG;EQ 40MG BASE TABLET / ORAL RLD, RS 2021-03-23 87673890dc5c…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N213072-001 ROSZET 10MG;EQ 5MG BASE TABLET / ORAL RLD 2021-03-23 6a51e52b5d6a…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N213072-002 ROSZET 10MG;EQ 10MG BASE TABLET / ORAL RLD 2021-03-23 6a51e52b5d6a…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N213072-003 ROSZET 10MG;EQ 20MG BASE TABLET / ORAL RLD 2021-03-23 6a51e52b5d6a…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N213072-004 ROSZET 10MG;EQ 40MG BASE TABLET / ORAL RLD 2021-03-23 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N213072-001 ROSZET 10MG;EQ 5MG BASE TABLET / ORAL RLD 2021-03-23 1c564ffb4f44…2024-02-18 07:12 UTC 2024-02 N213072-002 ROSZET 10MG;EQ 10MG BASE TABLET / ORAL RLD 2021-03-23 1c564ffb4f44…2024-02-18 07:12 UTC 2024-02 N213072-003 ROSZET 10MG;EQ 20MG BASE TABLET / ORAL RLD 2021-03-23 1c564ffb4f44…2024-02-18 07:12 UTC 2024-02 N213072-004 ROSZET 10MG;EQ 40MG BASE TABLET / ORAL RLD 2021-03-23 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N213072-001 ROSZET 10MG;EQ 5MG BASE TABLET / ORAL RLD 2021-03-23 ea1830bbd6c7…2023-12-20 04:57 UTC 2023-12 N213072-002 ROSZET 10MG;EQ 10MG BASE TABLET / ORAL RLD 2021-03-23 ea1830bbd6c7…2023-12-20 04:57 UTC 2023-12 N213072-003 ROSZET 10MG;EQ 20MG BASE TABLET / ORAL RLD 2021-03-23 ea1830bbd6c7…2023-12-20 04:57 UTC 2023-12 N213072-004 ROSZET 10MG;EQ 40MG BASE TABLET / ORAL RLD 2021-03-23 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N213072-001 ROSZET 10MG;EQ 5MG BASE TABLET / ORAL RLD 2021-03-23 a72a2bbeb626…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N213072-002 ROSZET 10MG;EQ 10MG BASE TABLET / ORAL RLD 2021-03-23 a72a2bbeb626…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N213072-003 ROSZET 10MG;EQ 20MG BASE TABLET / ORAL RLD 2021-03-23 a72a2bbeb626…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N213072-004 ROSZET 10MG;EQ 40MG BASE TABLET / ORAL RLD 2021-03-23 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N213072-001 ROSZET 10MG;EQ 5MG BASE TABLET / ORAL RLD 2021-03-23 9b2671bbb829…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N213072-002 ROSZET 10MG;EQ 10MG BASE TABLET / ORAL RLD 2021-03-23 9b2671bbb829…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N213072-003 ROSZET 10MG;EQ 20MG BASE TABLET / ORAL RLD 2021-03-23 9b2671bbb829…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N213072-004 ROSZET 10MG;EQ 40MG BASE TABLET / ORAL RLD 2021-03-23 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N213072-001 ROSZET 10MG;EQ 5MG BASE TABLET / ORAL RLD 2021-03-23 a67488948f0b…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N213072-002 ROSZET 10MG;EQ 10MG BASE TABLET / ORAL RLD 2021-03-23 a67488948f0b…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N213072-003 ROSZET 10MG;EQ 20MG BASE TABLET / ORAL RLD 2021-03-23 a67488948f0b…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N213072-004 ROSZET 10MG;EQ 40MG BASE TABLET / ORAL RLD 2021-03-23 a67488948f0b…
Observed Orange Book patent history# Patent history page 1 of 8 · 304 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-11-14 07:37:17 2026-10 N213072-001 10376470 2033-05-01 U-3095 Drug product 2021-03-29 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N213072-001 9763885 2033-05-01 U-3095 Drug product 2021-03-29 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N213072-002 10376470 2033-05-01 U-3095 Drug product 2021-03-29 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N213072-002 9763885 2033-05-01 U-3095 Drug product 2021-03-29 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N213072-003 10376470 2033-05-01 U-3095 Drug product 2021-03-29 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N213072-003 9763885 2033-05-01 U-3095 Drug product 2021-03-29 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N213072-004 10376470 2033-05-01 U-3095 Drug product 2021-03-29 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N213072-004 9763885 2033-05-01 U-3095 Drug product 2021-03-29 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 N213072-001 10376470 2033-05-01 U-3095 Drug product 2021-03-29 c2088c7a36db…2026-10-15 13:18:30 2026-09 N213072-001 9763885 2033-05-01 U-3095 Drug product 2021-03-29 c2088c7a36db…2026-10-15 13:18:30 2026-09 N213072-002 10376470 2033-05-01 U-3095 Drug product 2021-03-29 c2088c7a36db…2026-10-15 13:18:30 2026-09 N213072-002 9763885 2033-05-01 U-3095 Drug product 2021-03-29 c2088c7a36db…2026-10-15 13:18:30 2026-09 N213072-003 10376470 2033-05-01 U-3095 Drug product 2021-03-29 c2088c7a36db…2026-10-15 13:18:30 2026-09 N213072-003 9763885 2033-05-01 U-3095 Drug product 2021-03-29 c2088c7a36db…2026-10-15 13:18:30 2026-09 N213072-004 10376470 2033-05-01 U-3095 Drug product 2021-03-29 c2088c7a36db…2026-10-15 13:18:30 2026-09 N213072-004 9763885 2033-05-01 U-3095 Drug product 2021-03-29 c2088c7a36db…2026-09-14 22:38:34 2026-08 N213072-001 10376470 2033-05-01 U-3095 Drug product 2021-03-29 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213072-001 9763885 2033-05-01 U-3095 Drug product 2021-03-29 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213072-002 10376470 2033-05-01 U-3095 Drug product 2021-03-29 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213072-002 9763885 2033-05-01 U-3095 Drug product 2021-03-29 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213072-003 10376470 2033-05-01 U-3095 Drug product 2021-03-29 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213072-003 9763885 2033-05-01 U-3095 Drug product 2021-03-29 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213072-004 10376470 2033-05-01 U-3095 Drug product 2021-03-29 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213072-004 9763885 2033-05-01 U-3095 Drug product 2021-03-29 84e616aacf4f…2026-08-18 06:07:40 2026-07 N213072-001 10376470 2033-05-01 U-3095 Drug product 2021-03-29 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N213072-001 9763885 2033-05-01 U-3095 Drug product 2021-03-29 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N213072-002 10376470 2033-05-01 U-3095 Drug product 2021-03-29 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N213072-002 9763885 2033-05-01 U-3095 Drug product 2021-03-29 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N213072-003 10376470 2033-05-01 U-3095 Drug product 2021-03-29 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N213072-003 9763885 2033-05-01 U-3095 Drug product 2021-03-29 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N213072-004 10376470 2033-05-01 U-3095 Drug product 2021-03-29 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N213072-004 9763885 2033-05-01 U-3095 Drug product 2021-03-29 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N213072-001 10376470 2033-05-01 U-3095 Drug product 2021-03-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213072-001 9763885 2033-05-01 U-3095 Drug product 2021-03-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213072-002 10376470 2033-05-01 U-3095 Drug product 2021-03-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213072-002 9763885 2033-05-01 U-3095 Drug product 2021-03-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213072-003 10376470 2033-05-01 U-3095 Drug product 2021-03-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213072-003 9763885 2033-05-01 U-3095 Drug product 2021-03-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213072-004 10376470 2033-05-01 U-3095 Drug product 2021-03-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213072-004 9763885 2033-05-01 U-3095 Drug product 2021-03-29 011fe1cb6892…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 16 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 70661-001 ROSZET (rosuvastatin and ezetimibe) Althera Pharmaceuticals LLC NDA Current 70661-001 ROSZET rosuvastatin and ezetimibe Althera Pharmaceuticals LLC NDA Current 70661-001 ROSZET rosuvastatin and ezetimibe Althera Pharmaceuticals LLC NDA Current 70661-002 ROSZET (rosuvastatin and ezetimibe) Althera Pharmaceuticals LLC NDA Current 70661-002 ROSZET (rosuvastatin and ezetimibe) Althera Pharmaceuticals LLC NDA Current 70661-002 ROSZET (rosuvastatin and ezetimibe) Althera Pharmaceuticals LLC NDA Current 70661-003 ROSZET (rosuvastatin and ezetimibe) Althera Pharmaceuticals LLC NDA Current 70661-003 ROSZET (rosuvastatin and ezetimibe) Althera Pharmaceuticals LLC NDA Current 70661-003 ROSZET (rosuvastatin and ezetimibe) Althera Pharmaceuticals LLC NDA Current 70661-004 ROSZET (rosuvastatin and ezetimibe) Althera Pharmaceuticals LLC NDA Current 70661-004 ROSZET (rosuvastatin and ezetimibe) Althera Pharmaceuticals LLC NDA Current 70661-004 ROSZET (rosuvastatin and ezetimibe) Althera Pharmaceuticals LLC NDA Current 82120-125 ROSUVASTATIN AND EZETIMIBE rosuvastatin and ezetimibe SCOV3 LLC NDA AUTHORIZED GENERIC Current 82120-126 ROSUVASTATIN AND EZETIMIBE rosuvastatin and ezetimibe SCOV3 LLC NDA AUTHORIZED GENERIC Current 82120-127 ROSUVASTATIN AND EZETIMIBE rosuvastatin and ezetimibe SCOV3 LLC NDA AUTHORIZED GENERIC Current 82120-128 ROSUVASTATIN AND EZETIMIBE rosuvastatin and ezetimibe SCOV3 LLC NDA AUTHORIZED GENERIC Current
Documents# Document, Submission type, Date table Document Submission type Date 79497 SUPPL 2024-08-29 79488 SUPPL 2024-08-27 69080 ORIG 2021-10-25 66877 ORIG 2021-03-25 66861 ORIG 2021-03-24